Volume 6, Issue 5, Pages (March 2014)

Slides:



Advertisements
Similar presentations
From: MicroRNA let-7 Regulates 3T3-L1 Adipogenesis
Advertisements

Volume 8, Issue 5, Pages (May 2017)
Volume 16, Issue 5, Pages (August 2016)
Microprocessor Activity Controls Differential miRNA Biogenesis In Vivo
Volume 8, Issue 1, Pages (July 2014)
Local Inflammatory Cues Regulate Differentiation and Persistence of CD8+ Tissue- Resident Memory T Cells  Tessa Bergsbaken, Michael J. Bevan, Pamela J.
Volume 11, Issue 3, Pages (March 2012)
Volume 8, Issue 2, Pages (July 2014)
Volume 11, Issue 11, Pages (June 2015)
Volume 43, Issue 4, Pages (August 2011)
Volume 13, Issue 6, Pages (June 2013)
Volume 53, Issue 5, Pages (March 2014)
Volume 28, Issue 2, Pages (August 2015)
Volume 22, Issue 3, Pages e5 (September 2017)
Molecular Therapy - Methods & Clinical Development
Widespread Inhibition of Posttranscriptional Splicing Shapes the Cellular Transcriptome following Heat Shock  Reut Shalgi, Jessica A. Hurt, Susan Lindquist,
Volume 11, Issue 5, Pages (May 2012)
Volume 18, Issue 5, Pages (January 2017)
Volume 3, Issue 3, Pages (March 2013)
Volume 16, Issue 11, Pages (September 2016)
Volume 16, Issue 8, Pages (August 2016)
Molecular Mechanisms Regulating the Defects in Fragile X Syndrome Neurons Derived from Human Pluripotent Stem Cells  Tomer Halevy, Christian Czech, Nissim.
Volume 19, Issue 8, Pages (May 2017)
Volume 8, Issue 6, Pages (September 2014)
Volume 21, Issue 6, Pages (November 2017)
Volume 19, Issue 12, Pages (June 2017)
Volume 7, Issue 1, Pages 1-10 (July 2016)
Volume 6, Issue 2, Pages (January 2014)
Interplay between Nonsense-Mediated mRNA Decay and DNA Damage Response Pathways Reveals that Stn1 and Ten1 Are the Key CST Telomere-Cap Components  Eva-Maria.
Volume 46, Issue 1, Pages (April 2012)
Molecular Therapy - Nucleic Acids
Volume 10, Issue 3, Pages (March 2018)
Volume 9, Issue 5, Pages (November 2017)
TALEN Gene Knockouts Reveal No Requirement for the Conserved Human Shelterin Protein Rap1 in Telomere Protection and Length Regulation  Shaheen Kabir,
Volume 9, Issue 4, Pages (November 2014)
Volume 17, Issue 3, Pages (March 2015)
Volume 39, Issue 3, Pages (August 2010)
Volume 8, Issue 5, Pages (May 2017)
Volume 22, Issue 2, Pages (February 2005)
Volume 6, Issue 1, Pages (July 2009)
Alterations in mRNA 3′ UTR Isoform Abundance Accompany Gene Expression Changes in Human Huntington’s Disease Brains  Lindsay Romo, Ami Ashar-Patel, Edith.
Volume 21, Issue 9, Pages (November 2017)
Volume 11, Issue 11, Pages (June 2015)
Volume 18, Issue 6, Pages (December 2015)
A Major Role for Capsule-Independent Phagocytosis-Inhibitory Mechanisms in Mammalian Infection by Cryptococcus neoformans  Cheryl D. Chun, Jessica C.S.
Volume 17, Issue 6, Pages (June 2015)
An RB-EZH2 Complex Mediates Silencing of Repetitive DNA Sequences
Volume 5, Issue 6, Pages (December 2013)
Hung-Chun Chang, Leonard Guarente  Cell 
Volume 22, Issue 6, Pages (February 2018)
Volume 17, Issue 12, Pages (December 2016)
Volume 3, Issue 1, Pages (January 2013)
Volume 6, Issue 3, Pages (March 2016)
Volume 13, Issue 4, Pages (April 2013)
Volume 167, Issue 2, Pages e9 (October 2016)
Volume 39, Issue 3, Pages (August 2010)
Molecular Therapy - Nucleic Acids
Marijn T.M. van Jaarsveld, Difan Deng, Erik A.C. Wiemer, Zhike Zi 
Hepatocyte Growth Factor Regulates the miR-206-HDAC4 Cascade to Control Neurogenic Muscle Atrophy following Surgical Denervation in Mice  Wooshik Choi,
Nanog-Independent Reprogramming to iPSCs with Canonical Factors
The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI  Feng Xing, Shuo Wang, Jianhong Zhou  Molecular.
Volume 24, Issue 1, Pages (January 2006)
Volume 7, Issue 2, Pages (April 2014)
Volume 53, Issue 5, Pages (March 2014)
Volume 26, Issue 4, Pages e4 (January 2019)
Condensin and Hmo1 Mediate a Starvation-Induced Transcriptional Position Effect within the Ribosomal DNA Array  Danni Wang, Andres Mansisidor, Gayathri.
Volume 9, Issue 3, Pages (November 2014)
SUPT4H1 Depletion Leads to a Global Reduction in RNA
Volume 18, Issue 5, Pages (January 2017)
Endogenous Control of Immunity against Infection: Tenascin-C Regulates TLR4- Mediated Inflammation via MicroRNA-155  Anna M. Piccinini, Kim S. Midwood 
Presentation transcript:

Volume 6, Issue 5, Pages 928-937 (March 2014) miR-146a and miR-155 Delineate a MicroRNA Fingerprint Associated with Toxoplasma Persistence in the Host Brain  Dominique Cannella, Marie-Pierre Brenier-Pinchart, Laurence Braun, Jason M. van Rooyen, Alexandre Bougdour, Olivier Bastien, Michael S. Behnke, Rose-Laurence Curt, Aurélie Curt, Jeroen P.J. Saeij, L. David Sibley, Hervé Pelloux, Mohamed-Ali Hakimi  Cell Reports  Volume 6, Issue 5, Pages 928-937 (March 2014) DOI: 10.1016/j.celrep.2014.02.002 Copyright © 2014 The Authors Terms and Conditions

Cell Reports 2014 6, 928-937DOI: (10.1016/j.celrep.2014.02.002) Copyright © 2014 The Authors Terms and Conditions

Figure 1 Expression Profiling of Mature miRNAs in Human Fibroblasts following Infection by Type I (RH) versus Type II (ME49) Strains (A) Heatmap of quantitative miRNA profiling of RH- versus ME49-infected HFF cells. Hierarchical clustering was performed on the microRNAs that were differentially expressed between the two groups (n = 3 samples per strain). Gene expression values were mean log2 transformed and median centered for clustering. The scale of the heatmap is presented as fold change from the median value. The miRNAs list can be found in Table S2. (B) Northern blot analysis of cellular miRNA levels in human fibroblast cells after 24 hr of mock treatment (u.i) or upon infection with type I (RH) and type II (ME49) strains. Each infection was performed in triplicate. To control for loading, blots were stripped and rehybridized with the indicated miRNA and control probe. RNA markers are on the left. (C) Quantitative RT-PCR (qRT-PCR) analysis of both miR-146a and miR-155 levels in HFF cells left uninfected (u.i) or infected with type I (RH), type II (PRU and ME49), or type III (CTG) strains. microRNA levels were normalized by RNU24 levels. Mean values and SDs from three independent experiments are shown. (D and E) Time-dependent expression of (D) miR-146a, miR-146b and (E) primary transcripts pri-miR-146a in HFF cells after Toxoplasma type I (RH) and type II (ME49) infections. microRNA levels were assessed by qRT-PCR and normalized by RNU24 levels. Mean values and SDs from three independent experiments are shown. See also Figures S1 and S2 and Tables S1 and S2. Cell Reports 2014 6, 928-937DOI: (10.1016/j.celrep.2014.02.002) Copyright © 2014 The Authors Terms and Conditions

Figure 2 Genome-wide Scan for Association of miR-146a Expression with Toxoplasma Genetic Markers Reveals a Single Major QTL (A) Expression levels of miR-146a in the parental lines (type I, GT1, and type II, ME49) and 27 F1 progeny were assessed by qRT-PCR. Data are displayed as fold difference relative to the uninfected cells. microRNA levels were normalized by RNU24 levels. Mean values and SDs from three independent experiments are shown. (B) Plots indicate the log-likelihood association of expression of miR-146a (solid line) with markers aligned across the entire Toxoplasma genome in chromosome order. Significance levels determined by 3,000 permutations are indicated by horizontal lines (upper two lines are significant; lower line is suggestive). (C) Fine mapping of the Toxoplasma chromosome VIIb locus involved in strain specific regulation of miR-146a. The GRA15 locus on chromosome X is shown as a control. The QTL on VIIb is bound by genetic markers 55.m05046_at5 and 55.m010299_at3, which spans a region of 1.2 Mb including ROP16. The genotype for each of the F1 progeny at the locus is indicated by the boxes color (type I, yellow, and type II, red). See also Figure S3. Cell Reports 2014 6, 928-937DOI: (10.1016/j.celrep.2014.02.002) Copyright © 2014 The Authors Terms and Conditions

Figure 3 Suppression of miR-146a Expression Is Mediated by Type I ROP16 (A) Immunoblotting detection of phospho-STAT3(Y705) in nuclear cell lysates of HFF cells left uninfected (u.i.) or infected (24 hr) with the indicated strains. Toxofilin (parasite-specific) level is shown as loading control. (B and C) qRT-PCR analysis of miR-146a levels in HFF cells left uninfected (u.i) or infected with (B) type I or (C) type II Δrop16 strains versus their parental strains. microRNA expression levels were normalized by RNU24 levels. Mean values and SDs from three independent experiments are shown. (D) qRT-PCR analysis of miR-146a and miR-155 levels in HFF cells left uninfected (u.i) or infected with wild-type type II strain PruA7 or PruA7 ectopically expressing a type I allele of ROP16. microRNA expression levels were normalized by RNU24 levels. Mean values and SDs from six independent experiments are shown. (E) qRT-PCR analysis of miR-146a, described in Figure 3D, was repeated during a 24 hr Toxoplasma infection time course. Mean values and SDs from two independent experiments are shown. See also Figure S4. Cell Reports 2014 6, 928-937DOI: (10.1016/j.celrep.2014.02.002) Copyright © 2014 The Authors Terms and Conditions

Figure 4 Evidence for a Typical microRNA Fingerprint in Cyst-Containing Brains of Mice Chronically Infected by Type II Toxoplasma Strains (A) qRT-PCR analysis of selected microRNA levels in whole brains of Swiss mice left uninfected (n = 14 mice) or chronically infected (6–10 weeks postinfection) by 30–80 cysts of type II (ME49) strain (n = 14 mice) by intraperitoneal route. miRNA expression levels were expressed as normalized values using U6 snRNA as the endogenous control. Mean values and SDs from three independent experiments are shown. (B) Parasite burden and miRNAs expression were determined in wild-type Swiss mice intraperitoneally infected with a dose of 106 ME49 tachyzoites. Parasites were enumerated by qPCR in the serum and from brain homogenates by qPCR at the indicated times after infection. The expression of the aforementioned microRNA was assessed in the brain using qRT-PCR. miRNA expression levels were expressed as normalized values using U6 snRNA as the endogenous control. Mean values and SDs from two animals in each group are shown. (C) miRNA expression levels were assessed by qRT-PCR in brains of Swiss mice chronically infected by a type III (CTG) or a type II (ME49) Toxoplasma strains (105 tachyzoites by intraperitoneal route). miRNA expression levels were expressed as normalized values using U6 snRNA as the endogenous control. Mean values and SDs from six to eight animals in each group are shown. (D) Serological status by western blot analysis of mice left uninfected or infected as mentioned in Figure 4C. (E) Parasite burden in the brain of infected Swiss mice (six to eight animals/group) described above. Toxoplasma DNA PCR assay was performed with brain tissue sampled from mice at 7 weeks postinfection. ∗Significantly different (p < 0.05, Student’s t test). See also Figure S5. Cell Reports 2014 6, 928-937DOI: (10.1016/j.celrep.2014.02.002) Copyright © 2014 The Authors Terms and Conditions

Figure 5 miR-146a Expression Affects the Control of Toxoplasma In Vivo (A and B) Chronic cyst burden and microRNA expression were assessed in Swiss mice left uninfected or infected by the parental strain ME49 (n = 11) and F1 I × II progeny strains SF18 (n = 13) and SF28 (n = 8) using 105 tachyzoites and intraperitoneal route. (A) qRT-PCR analysis of miR-146a and miR-155 levels were assessed in mice brains. microRNA expression levels were normalized by U6 snRNA levels. Mean values and SDs from eight to 13 animals in each group are shown. (B) Cysts were enumerated by microscopy. ∗, ∗∗Significantly different (p < 0.05, Student’s t test). (C) C57BL/6 or C57BL/6 miR-146a−/− mice were intraperitoneally infected with a dose of 5 × 102 tachyzoites of PruA7 or PruA7+ROP16-I. Survival was monitored. Significance was tested using log-rank (Mantel-Cox) test and Peto & Peto modification of the Gehan-Wilcoxon test, ∗p = 8.13 × 10−6 and ∗∗p = 4.31 × 10−5 when compared to BL6 WT infected by PruA7 WT parasite strain. (D) qRT-PCR analysis of miR-146a levels were assessed in the brain of C57BL/6 WT and miR-146a−/− mice infected with PruA7 or PruA7+ROP16-I and compared to those of uninfected C57BL/6 WT mice. miRNA expression levels were expressed as normalized values using miR-U6 as the endogenous control. Mean values and SDs from three independent experiments are shown. (E) Peritoneal lavage fluid and serum were collected on day 4 after infection of C57BL/6 or C57BL/6 miR-146a−/− mice that had received an intraperitoneal (i.p.) dose of 103 PruA7 tachyzoites. Concentrations of IFN-γ were determined by ELISA. Data shown are means ± SD with n = 3 individual mice per mice genotype. Error bars represent SD from one experiment. ∗Significantly different from WT (p < 0.05, Student’s t test). (F) WT and miR-146−/− C57BL/6 mice were i.p. infected with 103 PruA7 tachyzoites. Parasites were enumerated using recovered i.p. contents at day 4 postinfection. Data shown are means ± SD (from three mice per mouse genotype). ∗Significantly different from WT (p < 0.05, Student’s t test). See also Figure S5. Cell Reports 2014 6, 928-937DOI: (10.1016/j.celrep.2014.02.002) Copyright © 2014 The Authors Terms and Conditions